UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference

September 24, 2018 at 4:05 PM EDT

SAN FRANCISCO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Bob Goeltz, chief financial officer, will present a corporate update at the Cantor Fitzgerald Annual Global Healthcare Conference in New York, NY on Wednesday, October 3, 2018, at 2:15 p.m. ET.

A live audio webcast will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITY
UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Investors
Endurance Advisors
Elizabeth Broder
ebroder@enduranceadvisors.com

Media
Austine Graff
Unity Biotechnology
707-593-6151
Austine.Graff@unitybiotechnology.com

UNITY color transp BG.jpg

Source: Unity Biotechnology, Inc.